生物駭客市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、應用、最終用戶、地區及競爭格局分類，2021-2031年）

全球生物駭客市場預計將從 2025 年的 216.8 億美元大幅成長至 2031 年的 405.7 億美元，複合年成長率為 11.01%。

該領域涵蓋了旨在改善和最佳化人體生物機能的多種醫療、營養和電子技術。其成長主要受慢性病日益增多以及以數據驅動、強調長壽的預防性醫療保健策略文化轉變的驅動。生物辨識監測設備和基因組檢測的廣泛應用進一步推動了這一趨勢，使消費者能夠精準地調整自身生理機能。根據個人化醫療聯盟預測，到2024年，個人化醫療將佔FDA核准的新型治療分子實體的約38%，凸顯了該產業對個人化生物解決方案日益成長的依賴。

儘管市場呈現上升趨勢，但仍面臨諸多障礙：DIY生物技術套件和未經監管的智慧補充劑缺乏完善的法規結構。這些消費品缺乏嚴格的安全監管，可能引發倫理困境和健康風險，導致潛在使用者心存疑慮。此外，缺乏標準化的管治也使得傳統醫療機構不願意推薦這些新技術。因此，由於創新與監管之間的鴻溝，新興生物駭客療法的安全性和有效性存在不確定性，該行業難以獲得充分的合法性和信任。

市場促進因素

在全球範圍內，文明病疾病和慢性病的發生率不斷上升，正推動消費行為發生根本性轉變，人們的關注點從被動的疾病管理轉向主動的生物最佳化。隨著非傳染性疾病對醫療基礎設施造成日益沉重的壓力，人們擴大轉向生物駭客策略，例如營養基因組學和代謝療法，以延長健康壽命並預防生理衰退。代謝健康危機的嚴重性加速了這一轉變。國際糖尿病聯盟報告稱，到2024年，全球將有約5.89億成年人患有糖尿病，這一數字凸顯了市場對解決潛在代謝問題的方案的迫切需求。

同時，先進的穿戴式生物感測器和連續監測工具的普及，正在為精準的自我監測和實驗奠定必要的技術基礎。這些設備不僅能追蹤簡單的活動，還能提供臨床層級的血糖動態、恢復指標和睡眠階段數據，使用戶能夠基於可靠的數據來最佳化自身的生理機能和生活方式。這些硬體的商業性成功也印證了市場需求。 2025年9月，Oura宣布其智慧戒指的廣泛應用推動了2024年營收超過5億美元。消費者的濃厚興趣源自於業界強勁的信心。正如Rock Health在2025年1月指出的那樣，美國數位醫療Start-Ups在2024年獲得了101億美元的創業投資，這將確保個人化醫療技術的持續創新，並推動生物駭客領域的發展。

市場挑戰

全球生物駭客產業擴張的一大障礙是缺乏針對未經監管的智慧補充劑和DIY生物試劑盒的標準化法規結構。由於缺乏統一的安全通訊協定，該領域面臨醫療機構的強烈質疑，他們不願意推薦缺乏嚴格臨床檢驗的干涉措施。這種監管的不確定性造成了市場環境的碎片化，導致功效聲明往往檢驗，增加了消費者在缺乏專家指導的情況下使用強效生物調節劑而遭受不良健康影響的風險。

這種潛在的責任風險因監管灰色地帶的消費保健品的廣泛使用而進一步加劇。根據責任營養委員會 (CRN) 的數據，到 2024 年，75% 的美國人將使用膳食補充劑，這意味著龐大的使用者群體幾乎不受任何嚴格的臨床監管。因此，監管機構無法跟上這種蓬勃發展的消費者需求，阻礙了生物駭客技術從利基愛好者群體發展成為一個完全整合的醫療產業。在安全標準統一之前，由於醫療專業人員和保險公司之間缺乏信任，市場將面臨停滯的風險。

市場趨勢

在再生醫學和以長壽為核心的抗衰老科技的推動下，市場正從一般健康維護轉向追求根本性的延壽策略。這項轉變的驅動力在於細胞重編程技術和老化細胞清除劑的商業性實用化日益增強，這些技術正從理論研究走向實際的臨床投資。大量資金湧入該領域，凸顯了其顛覆性潛力，因為機構投資者和高淨值人士尋求的是能夠逆轉生物老齡化而非僅僅控制症狀的技術。根據長壽投資者協會（Longevity Investors）2025年5月發布的年度報告，2024年全球用於長壽領域的資金籌措將達到84.9億美元，這標誌著資源正顯著地重新配置到這些先進的生理工程解決方案上。

同時，人工智慧 (AI) 正在透過提供高度個人化的健康洞察來變革整個產業，克服了千篇一律的營養建議的局限性。人工智慧平台現在可以整合複雜的資料流，包括持續監測、血液生物標記和基因檢測，從而為每位使用者創建動態的、高度個人化的最佳化通訊協定。這項技術進步恰逢消費者期望的重大轉變，越來越多的使用者傾向於選擇個人化介入措施而非千篇一律的產品，以確保最大的安全性和有效性。最新的市場數據也印證了這個趨勢。根據責任營養委員會 (CRN) 於 2024 年 11 月發布的《2024 年消費者調查》，69% 的膳食補充劑使用者在選擇保健產品時優先考慮個人化的攝取方案，這表明數據驅動的客製化將在該行業的未來發展中發揮至關重要的作用。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生物駭客市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按產品分類（穿戴式裝置、植入（晶片）、基因改造試劑盒、智慧型藥物、營養補充劑、行動應用程式等）
  • 透過應用（監測、治療、調查等）
  • 按最終用戶（製藥和生物技術公司、醫院和診所、法醫學實驗室、研究和學術機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美生物駭客市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲生物駭客市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太生物駭客市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲生物駭客市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲生物駭客市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球生物駭客市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Apple Inc.
• The ODIN
• Thync Global Inc
• Fitbit, Inc
• Nuanic Oy
• Health Via Modern Nutrition Inc
• Muse
• Thriveport, LLC
• Beeblesoft Ltd
• OsteoStrong

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Biohacking Market is projected to expand significantly, rising from a valuation of USD 21.68 Billion in 2025 to USD 40.57 Billion by 2031, reflecting a compound annual growth rate of 11.01%. This sector encompasses a diverse array of medical, nutritional, and electronic technologies aimed at enhancing human biological performance and optimization. The primary catalyst for this growth is the increasing prevalence of chronic illnesses alongside a cultural pivot toward data-centric, preventive healthcare strategies that emphasize longevity. This trajectory is bolstered by the widespread availability of biometric monitoring devices and genomic testing, which grant consumers the ability to enact precise physiological changes. According to the Personalized Medicine Coalition, personalized medicines represented roughly 38 percent of new therapeutic molecular entities approved by the FDA in 2024, highlighting the industry's deepening dependence on tailored biological solutions.

Despite this upward momentum, the market faces a substantial hurdle in the form of inadequate regulatory frameworks for do-it-yourself biology kits and unregulated smart supplements. The lack of strict safety oversight for these direct-to-consumer products introduces potential ethical dilemmas and health risks, fostering skepticism among potential users. Furthermore, this absence of standardized governance causes traditional healthcare providers to remain hesitant about endorsing these novel modalities. Consequently, the industry struggles to gain full legitimacy and trust, as the gap between innovation and regulation creates uncertainty regarding the safety and efficacy of emerging biohacking interventions.

Market Driver

The rising global incidence of lifestyle-related and chronic diseases is driving a fundamental transformation in consumer behavior, moving the focus from reactive disease management to proactive biological optimization. Faced with the growing pressure of non-communicable conditions on healthcare infrastructures, individuals are increasingly turning to biohacking strategies, such as nutrigenomics and metabolic therapies, to enhance healthspan and avert physiological deterioration. This shift is accelerated by the magnitude of the metabolic health crisis; the International Diabetes Federation reported that approximately 589 million adults globally were living with diabetes in 2024, a figure that emphasizes the urgent market need for solutions targeting underlying metabolic issues.

In parallel, the expansion of advanced wearable biosensors and continuous monitoring tools is establishing the technological foundation required for precise self-quantification and experimentation. These devices have advanced beyond simple activity tracking to provide clinical-level data on glucose dynamics, recovery metrics, and sleep stages, enabling users to fine-tune their biology and lifestyle based on hard evidence. The commercial success of this hardware illustrates its demand; Oura announced in September 2025 that it achieved over $500 million in revenue during 2024, fueled by the broad uptake of its smart rings. This consumer interest is supported by strong industry confidence, as Rock Health noted in January 2025 that U.S. digital health startups secured $10.1 billion in venture capital throughout 2024, guaranteeing sustained innovation in the personalized health technologies driving the biohacking field.

Market Challenge

A primary obstacle limiting the scalability of the global biohacking industry is the absence of standardized regulatory frameworks for unregulated smart supplements and do-it-yourself biology kits. Without uniform safety protocols, the sector encounters considerable skepticism from institutional healthcare providers who are reluctant to endorse interventions lacking rigorous clinical validation. This regulatory uncertainty fosters a fragmented environment where claims of efficacy often go unverified, thereby elevating the risk of negative health consequences for consumers attempting to use potent biological modulators without professional oversight.

The potential liability is exacerbated by the extensive use of consumer health products that exist within these regulatory gray zones. Data from the Council for Responsible Nutrition indicates that in 2024, 75 percent of Americans utilized dietary supplements, suggesting a massive user population operating largely without strict clinical supervision. Consequently, the inability of regulatory authorities to match this surging consumer demand prevents biohacking from evolving from a niche enthusiast community into a fully integrated medical industry. Until safety standards are unified, the market faces the risk of stagnation arising from a deficit of trust among both medical practitioners and insurance providers.

Market Trends

The market is increasingly characterized by the emergence of regenerative therapies and longevity-oriented age-tech, marking a shift from maintaining general wellness to pursuing radical life-extension strategies. This evolution is propelled by the commercial readiness of cellular reprogramming technologies and senolytics, which are moving from theoretical studies to becoming viable clinical investments. The substantial capital flowing into this area highlights its disruptive potential, as institutions and high-net-worth individuals search for technologies that can reverse biological aging rather than simply manage symptoms. According to the May 2025 annual report by Longevity Investors, global funding for the longevity sector reached $8.49 billion in 2024, indicating a significant redirection of resources toward these advanced physiological engineering solutions.

At the same time, artificial intelligence is transforming the industry by providing hyper-personalized health insights that overcome the shortcomings of generic nutritional guidance. AI-powered platforms can now aggregate complex data streams-including continuous monitoring, blood biomarkers, and genetic testing-to formulate dynamic, highly specific optimization protocols for individual users. This technological advancement corresponds with a major shift in consumer expectations, as users increasingly prefer tailored interventions over one-size-fits-all products to ensure maximum safety and effectiveness. This trend is confirmed by recent market data; the Council for Responsible Nutrition's November 2024 '2024 Consumer Survey' revealed that 69 percent of supplement users prioritize personalized regimens when choosing health products, affirming the essential role of data-driven customization in the sector's future growth.

Key Market Players

• Apple Inc.
• The ODIN
• Thync Global Inc
• Fitbit, Inc
• Nuanic Oy
• Health Via Modern Nutrition Inc
• Muse
• Thriveport, LLC
• Beeblesoft Ltd
• OsteoStrong

Report Scope

In this report, the Global Biohacking Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biohacking Market, By Product

• Wearables
• Implants (Chips)
• Gene Modification Kits
• Smart Drugs
• Supplements
• Mobile Apps
• Others

Biohacking Market, By Application

• Monitoring
• Treatment
• Research
• Others

Biohacking Market, By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Forensic Laboratories
• Research & Academic Institutes
• Others

Biohacking Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biohacking Market.

Available Customizations:

Global Biohacking Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biohacking Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps, Others)
  • 5.2.2. By Application (Monitoring, Treatment, Research, Others)
  • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Forensic Laboratories, Research & Academic Institutes, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Biohacking Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biohacking Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Biohacking Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Biohacking Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Biohacking Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biohacking Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Biohacking Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Biohacking Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Biohacking Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Biohacking Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Biohacking Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biohacking Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Biohacking Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Biohacking Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Biohacking Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Biohacking Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Biohacking Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biohacking Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Biohacking Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Biohacking Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Biohacking Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biohacking Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Biohacking Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Biohacking Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biohacking Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Apple Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. The ODIN
• 15.3. Thync Global Inc
• 15.4. Fitbit, Inc
• 15.5. Nuanic Oy
• 15.6. Health Via Modern Nutrition Inc
• 15.7. Muse
• 15.8. Thriveport, LLC
• 15.9. Beeblesoft Ltd
• 15.10. OsteoStrong

16. Strategic Recommendations

17. About Us & Disclaimer